UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Reduces Position in Henry Schein, Inc. (NASDAQ:HSIC)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its stake in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 11.4% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 892,686 shares of the company's stock after selling 114,421 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.72% of Henry Schein worth $65,077,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of HSIC. American Century Companies Inc. grew its position in shares of Henry Schein by 3.1% during the 2nd quarter. American Century Companies Inc. now owns 5,484,286 shares of the company's stock valued at $351,543,000 after acquiring an additional 162,477 shares during the period. FMR LLC boosted its position in Henry Schein by 7.8% during the third quarter. FMR LLC now owns 3,280,890 shares of the company's stock worth $239,177,000 after purchasing an additional 237,888 shares during the period. Nuance Investments LLC increased its stake in shares of Henry Schein by 22.3% in the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company's stock worth $166,072,000 after purchasing an additional 414,748 shares in the last quarter. Burgundy Asset Management Ltd. lifted its stake in shares of Henry Schein by 1.0% during the 2nd quarter. Burgundy Asset Management Ltd. now owns 1,640,379 shares of the company's stock valued at $105,148,000 after buying an additional 16,476 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in Henry Schein by 10.1% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,634,384 shares of the company's stock valued at $104,764,000 after buying an additional 149,517 shares in the last quarter. 96.62% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

HSIC has been the subject of several research analyst reports. Barrington Research reissued an "outperform" rating and set a $82.00 price objective on shares of Henry Schein in a research note on Wednesday, November 6th. Evercore ISI boosted their price target on shares of Henry Schein from $70.00 to $74.00 and gave the stock an "in-line" rating in a research note on Tuesday, October 8th. JPMorgan Chase & Co. lowered their price target on Henry Schein from $88.00 to $80.00 and set an "overweight" rating on the stock in a research report on Monday, August 12th. StockNews.com upgraded Henry Schein from a "sell" rating to a "hold" rating in a research report on Thursday, November 7th. Finally, UBS Group reduced their price target on shares of Henry Schein from $75.00 to $72.00 and set a "neutral" rating on the stock in a research report on Wednesday, August 7th. Six analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $79.38.

Insider Buying and Selling

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the sale, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP Lorelei Mcglynn sold 21,035 shares of the firm's stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the transaction, the senior vice president now owns 71,833 shares of the company's stock, valued at approximately $4,978,026.90. The trade was a 22.65 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

Henry Schein Trading Down 1.7 %

NASDAQ:HSIC traded down $1.29 during trading hours on Tuesday, hitting $75.21. The company had a trading volume of 1,449,944 shares, compared to its average volume of 1,397,936. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.63. The company has a market capitalization of $9.38 billion, a PE ratio of 30.95, a price-to-earnings-growth ratio of 2.20 and a beta of 0.87. The stock has a 50-day moving average price of $71.57 and a 200 day moving average price of $69.88.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, topping analysts' consensus estimates of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. During the same period in the prior year, the firm earned $1.32 EPS. The company's revenue was up .4% compared to the same quarter last year. On average, equities research analysts predict that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.